Skip to main content
Home
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH

Chronic kidney disease


Browse the latest news, expert commentary, and educational content on chronic kidney disease.


Highlights

10-11-2022 | Nephropathy | News

‘Strong justification’ for individualized albuminuria screening in type 1 diabetes

Screening people with type 1 diabetes for albuminuria at intervals determined by their baseline albumin excretion rate and glycated hemoglobin level reduces the time spent with undetected kidney disease, show DCCT/EDIC data.

08-11-2022 | SGLT2 inhibitors | News

Meta-analysis backs SGLT2 inhibitors for kidney disease

A meta-analysis published in The Lancet supports the use of SGLT2 inhibitors in people with chronic kidney disease, irrespective of whether they have type 2 diabetes.

07-06-2022 | ADA 2022 | Conference coverage | News

​​​​​​​ADA/KDIGO consensus: ‘Speaking the same language’ on CKD management

The ADA and KDIGO have produced a consensus statement on treating chronic kidney disease in people with diabetes.

More on chronic kidney disease

04-09-2023 | Type 2 diabetes | News

New model predicts kidney disease progression risk in type 2 diabetes

22-06-2023 | Cardiovascular outcomes | News

Finerenone modifies CKD-associated CV risk in albuminuric type 2 diabetes

26-05-2023 | Type 2 diabetes | News

Common antidiabetic add-on therapies offer similar renal outcomes

24-02-2023 | Risk factors | News

Mortality risk factors vary by age in type 2 diabetes

17-01-2023 | Lifestyle interventions | News

Healthy lifestyle wards off type 2 diabetes microvascular complications

08-12-2022 | Dapagliflozin | News

Dapagliflozin may cut hospitalization risk in CKD

02-12-2022 | Nephropathy | News

CKD strongest determinant of post-MI prognosis in type 1 diabetes

10-11-2022 | Nephropathy | News

‘Strong justification’ for individualized albuminuria screening in type 1 diabetes
Image Credits